A new precision medicine initiative at the dawn of exascale computing

Which signaling pathway and protein to select to mitigate the patient’s expected drug resistance? The number of possibilities facing the physician is massive, and the drug combination should fit the patient status. Here, we briefly review current approaches and data and map an innovative patient-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nussinov, Ruth, Jang, Hyunbum, Nir, Guy, Tsai, Chung-Jung, Cheng, Feixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785737/
https://www.ncbi.nlm.nih.gov/pubmed/33402669
http://dx.doi.org/10.1038/s41392-020-00420-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785737/
https://www.ncbi.nlm.nih.gov/pubmed/33402669
http://dx.doi.org/10.1038/s41392-020-00420-3

Ejemplares similares